News
Epizyme says chief business officer to resign - S&P Global
www.spglobal.com
Sep 18, — COO Matthew Ros will now become chief strategy and business officer. Ros previously served as COO/global head of oncology at Sanofi. › news-insights › trending
Form 8-K Epizyme, Inc. For: Oct StreetInsider
www.streetinsider.com
Oct 29, — Effective October 31, 2021, Matthew Ros, the Executive Vice President, Chief Strategy and Business Officer and principal financial officer ... › news
sorted by relevance / date